mRNA COVID-19 vaccines offer substantial protection from infection by the novel coronavirus, SARS-CoV-2, in the “real-world,” concludes a large study carried out at six regions across the U.S. including Salt Lake City, Utah. The performance of the vaccines was consistent with their performance in closely controlled clinical trials that led to their approval for emergency use.